Health & Fitness
Tue, January 13, 2009Mon, January 12, 2009Sun, January 11, 2009Fri, January 9, 2009Thu, January 8, 2009Wed, January 7, 2009Tue, January 6, 2009Mon, January 5, 2009Fri, January 2, 2009Thu, January 1, 2009Wed, December 31, 2008Tue, December 30, 2008Mon, December 29, 2008Wed, December 24, 2008Tue, December 23, 2008Mon, December 22, 2008Sun, December 21, 2008Fri, December 19, 2008Kinetic Concepts, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference
Published in Health and Fitness on Tuesday, January 6th 2009 at 9:06 GMT, Last Modified on 2009-01-06 09:07:27 by Market Wire
SAN ANTONIO--([ BUSINESS WIRE ])--Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco.
Mrs. Burzik will address conference attendees on Monday, January 12, 2009, at 11 a.m. PT (2 p.m. ET) and will discuss plans for the company's innovative technology, company performance, as well as strategies for continued growth.
A live audio Web cast of the presentation will be available on KCI's Web site at [ http://www.kci1.com/investor ] and it can also be accessed with the following link, [ http://metameetings.com/webcasts/jpmorgan/healthcare09 ].
About KCI
Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing – and the lives – of patients around the world.
KCI's three primary businesses include:
Advanced Wound Care– Includes KCI's proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System, which has been clinically demonstrated to promote wound healing through unique mechanisms of action while reducing the overall cost of treating patients with complex wounds.
Regenerative Medicine– Represented by KCI's LifeCell business and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.
Therapeutic Support Systems– Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, to reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size.
The Company employs approximately 7,000 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit [ www.kci1.com ].
